These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26032843)

  • 21. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial.
    Morgado M; Rolo S; Castelo-Branco M
    Int J Clin Pharm; 2011 Feb; 33(1):132-40. PubMed ID: 21365405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial.
    Borenstein JE; Graber G; Saltiel E; Wallace J; Ryu S; Archi J; Deutsch S; Weingarten SR
    Pharmacotherapy; 2003 Feb; 23(2):209-16. PubMed ID: 12587810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control.
    Carter BL; Coffey CS; Ardery G; Uribe L; Ecklund D; James P; Egan B; Vander Weg M; Chrischilles E; Vaughn T
    Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):235-43. PubMed ID: 25805647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control.
    Polgreen LA; Han J; Carter BL; Ardery GP; Coffey CS; Chrischilles EA; James PA
    Hypertension; 2015 Dec; 66(6):1145-51. PubMed ID: 26527048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control.
    Carter BL; Bergus GR; Dawson JD; Farris KB; Doucette WR; Chrischilles EA; Hartz AJ
    J Clin Hypertens (Greenwich); 2008 Apr; 10(4):260-71. PubMed ID: 18401223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial.
    Cooney D; Moon H; Liu Y; Miller RT; Perzynski A; Watts B; Drawz PE
    BMC Nephrol; 2015 Apr; 16():56. PubMed ID: 25881226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease.
    Anderegg MD; Gums TH; Uribe L; MacLaughlin EJ; Hoehns J; Bazaldua OV; Ives TJ; Hahn DL; Coffey CS; Carter BL
    Pharmacotherapy; 2018 Mar; 38(3):309-318. PubMed ID: 29331037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving blood pressure control in a pharmacist-managed hypertension clinic.
    Vivian EM
    Pharmacotherapy; 2002 Dec; 22(12):1533-40. PubMed ID: 12495164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension.
    Bogden PE; Abbott RD; Williamson P; Onopa JK; Koontz LM
    J Gen Intern Med; 1998 Nov; 13(11):740-5. PubMed ID: 9824519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Health Care Professionals in the Success of Blood Pressure Control Interventions in Patients With Hypertension: A Meta-Analysis.
    Mills KT; O'Connell SS; Pan M; Obst KM; He H; He J
    Circ Cardiovasc Qual Outcomes; 2024 Aug; 17(8):e010396. PubMed ID: 39027934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Centrally supported clinical pharmacist intervention to reduce clinical inertia in hypertension.
    Lowe RN; Kovac N; Lobo I; Billups SJ
    Am J Health Syst Pharm; 2023 Mar; 80(7):457-461. PubMed ID: 36480345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementing the new guidelines for hypertension: JNC 7, ADA, WHO-ISH.
    Carter BL
    J Manag Care Pharm; 2004 Sep; 10(5 Suppl A):S18-25. PubMed ID: 15369421
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a pharmacist intervention in Spanish community pharmacies on blood pressure control in hypertensive patients.
    Fikri-Benbrahim N; Faus MJ; Martínez-Martínez F; Alsina DG; Sabater-Hernández D
    Am J Health Syst Pharm; 2012 Aug; 69(15):1311-8. PubMed ID: 22821790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of a multidisciplinary information technology-supported program on blood pressure control in primary care.
    Rinfret S; Lussier MT; Peirce A; Duhamel F; Cossette S; Lalonde L; Tremblay C; Guertin MC; LeLorier J; Turgeon J; Hamet P;
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):170-7. PubMed ID: 20031834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of pharmacist care for hypertension in the Veterans Affairs patient-centered medical home: a retrospective case-control study.
    Zillich AJ; Jaynes HA; Bex SD; Boldt AS; Walston CM; Ramsey DC; Sutherland JM; Bravata DM
    Am J Med; 2015 May; 128(5):539.e1-6. PubMed ID: 25534422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Description of pharmacist interventions during physician-pharmacist co-management of hypertension.
    Von Muenster SJ; Carter BL; Weber CA; Ernst ME; Milchak JL; Steffensmeier JJ; Xu Y
    Pharm World Sci; 2008 Jan; 30(1):128-35. PubMed ID: 17710561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Open-label randomized trial of titrated disease management for patients with hypertension: Study design and baseline sample characteristics.
    Jackson GL; Weinberger M; Kirshner MA; Stechuchak KM; Melnyk SD; Bosworth HB; Coffman CJ; Neelon B; Van Houtven C; Gentry PW; Morris IJ; Rose CM; Taylor JP; May CL; Han B; Wainwright C; Alkon A; Powell L; Edelman D
    Contemp Clin Trials; 2016 Sep; 50():5-15. PubMed ID: 27417982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.